We also found differences in genotype frequency (AA, AG, and GG) between the CRC and healthy controls for Notch3 polymorphism (67%, 25.2%, and 7.8% vs 77.7%, 18.4% and 3.9%). This evidence concerns the gene NOTCH3 and colorectal carcinoma.